Effect of Deferasirox (Exjade) on labile plasma iron levels in heavily iron-overloaded patients with transfusion-dependent anemias enrolled in the large-scale, prospective 1-year EPIC trial / J.B. Porter, M.D. Cappellini, A. El Beshlawy, A. Kattamis, J.F. Seymours, J.W. Lee, H. Nick, D. Habr, G. Domokos, A. Hmissi, A. Taher. - In: BLOOD. - ISSN 0006-4971. - 112:11(2008 Nov), pp. 1322-1322. ((Intervento presentato al 50. convegno ASH annual meeting and exposition tenutosi a San Francisco, USA nel 2008.
Effect of Deferasirox (Exjade) on labile plasma iron levels in heavily iron-overloaded patients with transfusion-dependent anemias enrolled in the large-scale, prospective 1-year EPIC trial
M.D. CappelliniSecondo
;
2008
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
